BPMUF OTC
Basilea Pharmaceutica AG
1W: -1.5%
1M: -1.5%
3M: +26.5%
YTD: +20.6%
1Y: +12.6%
3Y: +86.0%
5Y: +41.2%
$76.25
-1.15 (-1.49%)
Weekly Expected Move ±0.7%
$75
$76
$76
$77
$77
Overview
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Cash Flow Trends
Operating Cash Flow
$62M
-16.5% ▼
Capital Expenditures
$3M
-46.3% ▼
5Y CAGR: +3.0%
Free Cash Flow
$59M
-18.0% ▼
Dividends Paid
$0
+0.0% ▲
Buybacks
$0
+0.0% ▲
Net Change in Cash
$14M
-76.6% ▼
Cash Flow Composition
Year-over-Year Growth
View Full Cash Flow Statement
| Line Item | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| — Operating Activities — | |||||
| Net Income | -$7M | $12M | $10M | $78M | $40M |
| Depreciation & Amort. | $754K | $1M | $2M | $2M | $4M |
| Stock-Based Comp. | $4M | $4M | $5M | $5M | $0 |
| Change in Working Capital | -$33M | -$11M | -$5M | $9M | $9M |
| Other Non-Cash Items | $1M | $456K | $3M | -$19M | $4M |
| Operating Cash Flow | -$32M | $7M | $14M | $74M | $62M |
| — Investing Activities — | |||||
| Capital Expenditures | -$860K | -$3M | -$813K | -$2M | -$3M |
| Acquisitions (Net) | -$2M | $0 | $0 | $781K | $0 |
| Investment Purchases | -$35M | $0 | $0 | $0 | $0 |
| Investment Sales | $41M | $95M | $0 | $0 | $0 |
| Other Investing | $0 | $1K | -$221K | -$82K | $0 |
| Investing Cash Flow | $4M | $92M | -$1M | -$1M | -$3M |
| — Financing Activities — | |||||
| Net Debt Issuance | -$23M | $74M | -$59M | -$16M | -$22M |
| Stock Repurchased | -$4M | $0 | -$381K | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 | $0 |
| Other Financing | $44M | -$124M | $0 | $0 | -$75K |
| Financing Cash Flow | $17M | -$45M | -$57M | -$13M | -$21M |
| Net Change in Cash | -$11M | $54M | -$44M | $60M | $14M |
| Cash End of Period | $55M | $109M | $64M | $125M | $30M |
| Free Cash Flow | -$33M | $4M | $13M | $73M | $59M |